- Home
- BHVN vs CRMD Comparison
BHVN vs CRMD Comparison
Compare BHVN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHVN | CRMD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 958.1M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BHVN | CRMD |
|---|---|---|
| Price | $10.76 | $7.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $30.36 | $15.29 |
| AVG Volume (30 Days) | 2.9M | ★ 4.1M |
| Earning Date | 03-02-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $631.55 |
| Revenue Next Year | N/A | $13.99 |
| P/E Ratio | ★ N/A | $3.26 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $7.48 | $5.60 |
| 52 Week High | $44.28 | $17.43 |
Technical Indicators
Market Signals| Indicator | BHVN | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 38.99 |
| Support Level | $10.61 | $7.33 |
| Resistance Level | $12.90 | $8.53 |
| Average True Range (ATR) | 0.80 | 0.41 |
| MACD | -0.23 | 0.13 |
| Stochastic Oscillator | 17.66 | 49.49 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.